EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 143 filers reported holding EPIZYME INC in Q1 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $37,000 | +5.7% | 25,338 | +81.7% | 0.00% | 0.0% |
| Q4 2021 | $35,000 | -73.1% | 13,948 | +27.6% | 0.00% | -87.5% |
| Q3 2020 | $130,000 | -78.9% | 10,934 | -56.3% | 0.01% | -84.9% |
| Q4 2019 | $615,000 | +3.2% | 25,000 | -47.3% | 0.05% | -1.9% |
| Q2 2019 | $596,000 | +67.4% | 47,474 | +41.3% | 0.05% | +54.3% |
| Q3 2018 | $356,000 | -34.9% | 33,592 | -7.2% | 0.04% | -69.3% |
| Q2 2017 | $547,000 | – | 36,182 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 31,833,334 | $47,750,000 | 19.42% |
| MPM BioImpact LLC | 3,425,202 | $3,939,000 | 1.06% |
| Palo Alto Investors LP | 6,774,541 | $7,791,000 | 0.60% |
| Foresite Capital Management I, LLC | 143,759 | $165,000 | 0.29% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 6,603,870 | $7,594,000 | 0.23% |
| Rock Springs Capital Management LP | 7,267,696 | $8,358,000 | 0.21% |
| BP PLC | 24,687 | $28,000 | 0.16% |
| NewGen Asset Management Ltd | 250,000 | $288,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 467,836 | $538,000 | 0.07% |
| Frazier Life Sciences Management, L.P. | 739,369 | $850,000 | 0.07% |